AI assistant
Sending…
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2020
May 15, 2020
32163_dirs_2020-05-15_b1a9e448-1a63-4245-bbcd-3f5d18d911f7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2020-05-13
Reporting Person: Dreyer Scott (EVP & Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-13 | Common Stock | S | 4434 | $22.61 | Disposed | 48441 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019 and modified on March 5, 2020.
More from COLLEGIUM PHARMACEUTICAL, INC
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Annual Report
2026
Feb 26